Browse Category

NYSE:HHH News 19 December 2025

Howard Hughes Holdings (HHH) Stock Falls on Dec. 19, 2025 After $2.1B Vantage Deal: Latest News, Analyst Forecasts, and Key Risks

Howard Hughes Holdings (HHH) Stock Falls on Dec. 19, 2025 After $2.1B Vantage Deal: Latest News, Analyst Forecasts, and Key Risks

Howard Hughes Holdings Inc. (NYSE: HHH) stock traded sharply lower on Friday, Dec. 19, 2025, as investors digested the company’s headline-grabbing move to buy specialty insurer and reinsurer Vantage Group Holdings in a deal valued at about $2.1 billion. HHH shares were hovering around $79–$80, down roughly 5% on the day, after opening near $84. Investing.com The decline comes one session after the announcement sparked a more upbeat first reaction in parts of the market, highlighting the core tension in today’s Howard Hughes story: HHH is no longer pitching itself as “just” a real estate developer—it’s pitching itself as the

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop